Highlights
Monitoring of successful antibiotics treatment by HNL Dimer in plasma. Read our press release (https://www.eurekalert.org/news-releases/1064223)
Improve the diagnostic potential of HNL even further
In our recent publication on fMLP-activated whole blood we showed that it was possible to achieve an even greater diagnostic distinction between acute infections caused
An important notice about the assay of eosinophil and neutrophil granule proteins in serum
Avoid blood collection tubes containing clot activators in the form of silica microcrystalls!!!
How to treat bacterial infections?
Antibiotics resistance is a serious and fast developing global problem. If we do not act we may not any longer be able to successfully treat
Our novel EPO ELISA has been successfully published
We recently launched a specific ELISA for the measurements of EPO (Eosinophil Peroxidase) in any human biological fluids or cell extracts.
HNL in serum or whole blood after activation
The superior diagnostic performance of HNL in infectious disease is achieved in serum or after activation of neutrophils in whole blood.
HNL/NGAL in acute kidney injury
HNL and NGAL are two names for the same protein. An additional name is lipocalin 2.
Is plasma HNL Dimer the superior means to monitor antibiotics treatment?
We have constructed an HNL assay that uniquely measures the dimeric form of HNL. The HNL Dimer has its origin in neutrophils. As shown in our
HNL in infections
Three recent publications showed the superiority of HNL as a diagnostic and discriminatory means in infectious disease.